Actively managed fund

Polar Capital Biotech I GBP Hdg Inc

ISIN
IE00BFX4HX56
Category
Other Equity

How good is this fund, really?

See the rating in the app

About Polar Capital Biotech I GBP Hdg Inc

Biotechnology, diagnostics and life sciences tools companies from around the world make up Polar Capital Biotechnology, which aims to preserve capital and achieve long-term growth. The portfolio is spread across countries, biotech sub-sectors and company sizes. Active management targets the NASDAQ Biotechnology Net Total Return Index (USD), which is also the hurdle for a performance fee of 10% of returns above it; for this class that fee came to 0.82% in the year to 31 December 2025. The ongoing charge is 1.10%. Class I Hedged GBP Distribution shares may pay an annual dividend at the directors' discretion. The fund launched on 31 October 2013 and this class on 16 January 2018. It is an SFDR Article 8 fund rated 6 out of 7 for risk, with a recommended horizon of five years or more.

Watch this fund for free Add Polar Capital Biotech I GBP Hdg Inc to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy Polar Capital Biotech I GBP Hdg Inc — platforms and fees

Sold on 2 platforms we follow.

Polar Capital Biotech I GBP Hdg Inc — its category

Other Equity — PowerFunds rates 2,983 funds in this category every month.

Other equity funds →

Other funds